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ABSTRACT 
Estimates for the UK suggest that alcohol consumption during pregnancy and prevalence of Fetal 
Alcohol Spectrum Disorder (FASD) – the most common neurodevelopmental condition – are high.   
Considering the significant health and social impacts of FASD, there is a public health imperative to 
prioritise prevention, interventions and support.  In this article we outline the current state of play 
regarding FASD knowledge and research in the UK, which is characterised by a lack of evidence, a 
lack of dedicated funding and services, and consequently little policy formulation and strategic 
direction.  We highlight progress made to date, as well as current knowledge and service gaps to 
propose a way forward for UK research.   
Keywords: Adolescent health, syndrome, neonatology 
 
 
 
What is known about this topic  
- Fetal Alcohol Spectrum Disorders (FASD) is a diagnostic term used to describe the physical 
and neurological deficits caused by prenatal alcohol exposure 
- Alcohol use during pregnancy in the UK is estimated to be high, but recognition of FASD is 
low 
What this study adds 
- An overview of current evidence and activities in the UK relating to FASD 
- A recognition of the current gap in identification, management, service provision, data and 
intelligence, and prevention in the UK 
- Suggestions for next steps in creating better recognition for the condition to ensure support 
for children and their families 
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INTRODUCTION 
Fetal Alcohol Spectrum Disorder (FASD) is a diagnostic term used to describe the physical and 
neurological deficits caused by prenatal alcohol exposure (PAE).  Individuals affected by FASD have 
atypical neurodevelopment,[1] although only 5–10% have physical features such as dysmorphology 
and prenatal or postnatal growth impact.[2,3]  FASD is often referred to as a hidden disability, as the 
vulnerabilities in understanding, social skills and decision-making can be masked by an age-
appropriate physical demeanour, reading level and expressive language skills.[4]  Undiagnosed and 
unsupported individuals struggle to meet the expectations of society.  Individuals with FASD are 
more likely to require access to health care services, require additional educational support, and  
may disproportionally appear in the criminal justice system.[4]  Early identification and support is 
associated with improved educational attainment and a reduction in behavioural and physical 
problems, social exclusion and mental illnesses[2].  The scale of FASD and its impact on the UK 
population is grossly under-recognised.  This has a devastating impact on individuals, families and 
society as a whole.  The cost of FASD for the UK is estimated at £2 billion per annum, [5]  based on 
US data that primarily includes healthcare costs and is a likely underestimate of wider costs, such as 
social care and education. 
 
Current human and animal evidence does not indicate a safe level of alcohol consumption in 
pregnancy.[6]  A complex interplay of maternal genetics, nutritional and environmental exposures 
are likely to impact on whether alcohol exposure will result in harm at an individual level.[7]  Whilst 
consuming higher levels of alcohol is acknowledged as a risk, individual harm associated with low to 
moderate levels of alcohol consumption is less well characterised.[8] Animal models show clear dose 
response relationships with gestational day,[9] with even chronic low dose exposure showing effects 
in older offspring.[10]  The uncertainty of risk of consuming alcohol at lower levels during pregnancy 
has been acknowledged in drinking guidelines in the UK and internationally.   
Developments in the last decade 
It was only in 2016 that the four Chief Medical Officers of the UK harmonised their 
recommendations to advise abstinence in their revised guidelines.[6]  This development came 
alongside international guidelines on identification and management of substance use in pregnancy 
from the World Health Organization (WHO) [11], and across the world a focus on training midwives 
and other professionals has been key. While there have been initiatives focused on increasing 
support for women who use alcohol or other substances during pregnancy, attempts at punitive 
measures have also been evident. In 2015, the Court of Appeal in England dismissed a case where 
compensation was sought on behalf of a child with Fetal Alcohol Syndrome (FAS).   
In the UK, the establishment of the All Parliamentary Party Group on FASD [5] is an important step 
towards increased political engagement in the topic.  A significant gap, however, remains in parent 
support, which is limited and primarily delivered by the voluntary sector.  
In terms of wider awareness raising, warning labels on alcoholic beverages have been proposed as a 
potentially beneficial public health intervention, [12] but few countries have mandated pregnancy 
warning labels and progression through international trade agreement forum has been limited.[13]  
In 2020, Australia progressed to make pregnancy warning labels mandatory after two decades of 
advocacy and opposition from the alcohol industry.  
This remainder of this paper provides an overview of the current FASD evidence base from a UK 
perspective.   
PREVALENCE 
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There are no reliable estimates of the prevalence of FASD in the UK, leading to a lack of awareness, 
which is a barrier for implementing successful prevention programmes and developing services.  
Prevalence of FASD can be estimated by quantifying the number of women who consume alcohol 
during pregnancy and modelling the likely outcome in terms of FASD. This relies on self-report, 
which can be problematic because of reporting bias.[14,15]  Estimates of alcohol consumption 
during pregnancy using Global Burden of Disease models suggest 41.3% of pregnant women in the 
UK consume alcohol at some point during pregnancy, which can be extrapolated to a modelled 
estimate of FASD prevalence of 3.2%.[16]  Direct estimates of alcohol consumption in pregnancy in 
the UK were produced from the SCOPE (Screening for Pregnancy Endpoints) study, which suggested 
75% of women in the UK consumed some alcohol during pregnancy, with 33% reporting binge 
drinking at least once.[17]  The Infant Feeding Survey (IFS), last conducted in 2010 (now 
discontinued), found that 49% of women who drank alcohol before pregnancy stopped and a further 
46% reduced their consumption.[18]  These figures conceal significant age and demographic 
differences in consumption: e.g. the IFS found a higher prevalence among women aged over 35 
years and in those in managerial and professional occupations, compared to those who had never 
worked.   
 
The second method of estimating FASD prevalence is through active case ascertainment studies, 
which are considered gold standard, [19]  but are yet to be completed in the UK.  Passive 
surveillance screening studies in Scotland and reports from hospital episodes statistics in England 
demonstrate lower levels of FASD than would be expected based on the prevalence of alcohol 
exposure in pregnancy.[20,21]  Under-diagnosis may occur for a variety of reasons, including lack of 
knowledge and specialist training amongst health professionals, and late emergence of behavioural 
difficulties by which time evidence of prenatal alcohol exposure may be lacking.  A screening 
algorithm applied to cohort data for one region of the UK suggests 6–17% of children met criteria for 
FASD.[3] Given the high FASD prevalence, it is unlikely that highly specialised services for diagnosis 
and support of affected individuals would meet the demand.   
 
ASSESSMENT AND DIAGNOSIS  
 
FAS was first described over 40 years ago, yet the first UK diagnostic guidelines for individuals with 
PAE were published in 2019.[22]  As the UK evidence base on FASD is limited, this guideline was 
largely based on best practice from international sources.[23]  A pilot study of FASD assessment in 
NHS Ayrshire and Arran, Scotland, compared specialist versus mainstream models, the latter utilising 
Child & Adolescent Mental Health & Community Paediatric Services.  The study found disorder-
specific pathways less favourable compared with mainstream neurodevelopmental pathways.  
Mainstream pathways facilitate assessment of other conditions, such as Attention Deficit 
Hyperactivity Disorder (ADHD), Developmental Coordination Disorder (DCD) and Autism Spectrum 
Disorder (ASD), alongside FASD. [24]  The complexity of overlaps and relatively high prevalence of 
these conditions, and overlap in methods, makes mainstream pathways a sensible and cost-effective 
solutions to provide diagnostic services. Optimum pathways comprise input from a multidisciplinary 
team, ideally with access to clinical psychologists, paediatricians, psychiatrists, speech and language 
therapists, occupational therapists, alongside carers and education professionals.  Individuals with 
FASD require mental health and/or risk assessment as part of their assessment.   
 
Feedback from individuals with FASD highlight the importance of diagnosis and a holistic 
understanding of strengths and difficulties; all of which can be described as interventions in 
themselves.[24] These can be addressed through a comprehensive neurodevelopmental approach. 
To determine FASD, evidence of PAE alongside significant differences across three brain domains 
and/or brain anatomy is required.[22]  Although best practice advocates for a neuropsychological 
profile of strengths and weaknesses, further research is required to identify the most sensitive and 
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specific tests,[25] alongside feasibility studies for NHS implementation. To date, however, there are 
very few places in the UK that offer such approaches. Two services exist in southern England and 
one of these FASD services has existed for over a decade.  Following national training and ongoing 
government support, FASD assessments are becoming more accessible in Scotland. Other areas are 
yet lacking.  
 
In Scotland, direct government support has led to significant progress over recent years by 
improving the awareness and recognition of FASD.  In 2019, the Scottish SIGN Guideline 156 – 
Children and Young People Exposed Prenatally to Alcohol  was published.[22] The guidelines provide 
recommendations based on best available evidence and consensus for the assessment and diagnosis 
of children and young people affected by PAE to aid service development and delivery.  These 
developments are key to improving the lives of people living with FASD.   
FASD is occasionally diagnosed elsewhere: very obvious cases (e.g. those with a clear history of PAE 
and physical stigmata) may be diagnosed in generic paediatrics and genetics services. There is little, 
if any, assessment in high risk settings such as child protection and criminal justice. 
 
Interventions following identification 
Internationally, the quality of research into interventions for people affected by FASD remains 
limited.[26]  Reviews of the literature over the last decade have shown development of ideas, but 
limited progress towards gold standard randomised controlled trials (RCTs).[26,27]  Two areas can 
be used to highlight this: parenting and medication.  Several parenting interventions have been 
developed in different areas of the world, ranging from methods of psychoeducation to direct 
intervention, of which few have been tested in an RCT.[26]  One promising pilot RCT is the “GoFAR 
approach”,[28] which targets adaptive function and self-regulation; cited within the Diagnostic and 
Statistical Manual of Mental Disorders (DSM) as central difficulties in FASD. However, a larger scale 
trial is still awaited.  Whilst no medications appear to improve FASD-specific outcomes, the 
effectiveness of medication for comorbid conditions such as ADHD has been explored.  Whilst a 
small-scale trial has been conducted, it was under-powered to draw firm conclusions.  Instead a 
consensus of practice-based evidence currently guides the treatment of comorbid FASD and 
ADHD.[29]  These areas highlight that while globally much work has been done to improve the 
quality of life and understanding of FASD, there is a need to systematically and robustly evaluate 
interventions. This needs to be appropriately funded to develop gold standard evidence that can 
inform guidance development groups, such as the UK National Institute for Health and Care 
Excellence (NICE).  
 
PREVENTION OF ALCOHOL EXPOSED PREGNANCIES  
Preventing unplanned pregnancies may be a key step in preventing an alcohol exposed pregnancy 
(AEP). The CHOICES intervention focuses on women who may become pregnant and has been tested 
in RCTs primarily in the USA. [30] These interventions have shown effectiveness in reducing risky 
alcohol use but also increasing contraceptive use, in student populations as well as women recruited 
from wider community settings (e.g. see [31]). Trials of this intervention have to date not been 
undertaken in the UK. International research has also explored trajectory of drinking behaviours in 
women of childbearing age and how these change or may transfer into, and after, pregnancy.[32]  
Replication of such research in a UK context, along with exploration of causal factors and attitudes 
surrounding prenatal alcohol use, is needed.  
Providing appropriate antenatal and postnatal care for women who drink alcohol is only possible if 
those at risk can be identified.  Self-reports are influenced by factors such as recall bias, the patient- 
clinician relationship, expected social norms, fear of perceived judgement [14], and time point when 
women are asked about their alcohol use.[33] There is a lack of evidence for the accuracy of self-
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report alcohol screening instruments in antenatal settings in the UK. [34]  However, a bespoke 
screening tool has been developed and implemented in the North East of England and awaits 
evaluation. To provide further understanding of prevalence of PAE, studies have evaluated blood 
biomarkers, alone or a combination with self-report. A UK study found that these biomarkers are 
efficacious in obtaining measures of alcohol use during pregnancy higher than that of self-report. 
[35]. While a systematic review of a range of biomarkers concluded that the published evidence was 
not sufficient for supporting routine use in antenatal care,[36] review of blood biomarkers along 
with self-report measures [37] and recent international work have shown promising results 
indicating that further investigation is warranted.[38]   
 
Despite the known issues with identifying alcohol use through self-report, results from self-reported 
screening assessments can inform the delivery of a brief intervention. [39]  The efficacy of brief 
interventions in antenatal care is uncertain primarily due to heterogeneity and varying quality of 
trials assessing their use for pregnant women. [40]  Qualitative research from Scotland, where a 
national Alcohol Brief Interventions (ABI) programme was introduced in 2009, shows that 
implementation of ABIs in antenatal care varied between different health boards in relation to 
screening tools used.  A key aspect of improving low rates was to focus on a culturally appropriate 
conversation and such local adaptations were necessary to successfully implement ABIs in 
practice.[41]  Doi et al.[42] similarly found that Scottish midwives were positive about delivering 
ABIs, though the midwife-woman relationship may not be well established at the initial 
appointment, making it harder to discuss the topic.  More recent work, including midwives from 
across the UK, indicated that approaches to assessing women’s alcohol use varies nationally and 
even at regional level, with no uniform approach.[43]  While there is some evidence that preventive 
approaches vary across the UK, further evaluation of different approaches and their effectiveness is 
needed.  
Training of professionals 
FASD training is needed across different professional groups.  The relatively low levels of training in 
the UK are reflected in significant knowledge gaps, and low levels of awareness and confidence.[44]  
Survey data of UK midwives showed that 19% had not received any training on alcohol screening or 
management during their pre-qualification training and 33% had not received any training after 
qualifying.[43]  A survey of paediatricians showed only half had diagnosed FASD and over a third 
expressed concerns around stigmatisation of diagnosis.[45]  These factors could explain the 
considerable under-diagnosis in the UK.  Screening for alcohol use and FASD, and the onward 
referral processes, are acknowledged learning requirements for healthcare professionals.  Even so, 
current practices and services are diverse, haphazard and lack national guidance.[45]  Given the high 
prevalence of FASD, comprehensive multi-agency training is required, targeting health professionals, 
social services, child protection agencies, criminal justice officials and teachers. The majority of early 
childhood educators in the UK report knowing little or nothing at all about FASD and feel ill-
equipped to support children with FASD.[46]  This concurs with anecdotal evidence and reports from 
teachers in primary and secondary education who also received inadequate or no initial teacher 
training or continued professional development on this topic.[47]   
ONGOING ACTIVITIES   
Funded studies into FASD in the UK remain limited, in contrast with, for example, the US, where the 
National Institute on Alcohol Abuse and Alcoholism (NIAAA) has recently issued a US$30m call 
specifically for FASD research.  Researchers at the University of Salford are undertaking the first 
active case ascertainment study of FASD in the UK, in a project funded by Greater Manchester 
Combined Authority (GMCA).  The Salford team are also developing a training programme for 
parents of children with FASD, designed to reduce stress at home and improve life outcomes, in a 
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project funded by the Medical Research Council.  A multi-pronged campaign is underway to reduce 
AEPs in the Greater Manchester region.  This includes FASD-specific training for professionals, and 
addiction and contraception support for women at risk of an AEP based on the CHOICES intervention 
[30], routine alcohol screening at antenatal care, and an online public health campaign to increase 
understanding of FASD.  The impact of these interventions will be evaluated by further research 
funded by GMCA.  Another prevention-focused study, led by University of Hull, involving midwives in 
the North East of England has been funded by the National Institute for health Research (NIHR) and 
supported by the regional antenatal care network.  
Funding from the US’s NIAAA continues to support the development in Oxford and Brighton of 3D 
facial analysis of individuals with FASD.  Birmingham City University have committed funding to a 
four-year doctoral post to explore the lived experiences of adults with FASD in recognition of the 
paucity of research in this area.  Other unfunded research and data continue to be presented from 
careful evaluation of clinical cohorts.  These datasets come with inherent biases, yet provide insights 
into future hypothesis testing and allow evaluation of ‘natural experiments’, i.e. situations that arise 
by chance but allow an experimental approach which cannot be replicated in research samples for 
ethical reasons.[48]  Without a strategic approach and a coordinated research strategy in the UK to 
produce specific calls for research in the area, it is likely to remain an under studied area. 
CONCLUSIONS 
 
The health and social impacts of FASD in the UK are significant and is a public health issue in need of 
further attention.  There is a lack of evidence and prioritisation of FASD, leading to gaps in support 
services, research funding, and acknowledgement of the condition within policy documents, 
professional education programmes, and clinical practice.  However, the Scottish Government has 
made a clear commitment to FASD and supporting those affected.[49]  The Scottish Alcohol 
Framework includes approaches to prevention, diagnosis, research commissioning, and data 
collection for the years to come.  
Estimates indicate that FASD is more common than, for example, ASD,[50] yet in contrast to services 
for ASD there is no coordinated investment in diagnosis or support.   Only a few places in the UK 
have dedicated services that provide the important information families need to put appropriate 
support in place.  Most of the evidence currently available for the UK is based on estimates from 
international work, a small number of UK-based research studies, or evidence syntheses.  We 
propose that in order to address this important public health issue, FASD needs to be appropriately 
recognised in health and social policy, prioritised through research and service provision, and 
adequately addressed in education of professionals likely to come into contact with pregnant 
women and individuals with FASD.   
Specifically, we recommend that there is investment in:  
 accurate data collection of alcohol exposure peri-conception and during pregnancy;  
 sustained follow-up of women and children;  
 active case ascertainment studies in the general population, and specific populations, e.g.  
care-experienced children and young people;  
 the mental health impact of individuals with FASD when seen together with comorbid 
traumatic experiences and prison populations; and 
 service design and professional education to ensure coordinated diagnosis and support can 
be provided to affected individuals and their families.    
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This will provide accurate prevalence figures and allow robust estimates of the (likely great) cost of 
this condition to UK society.   The recent policy and clinical guidelines development in Scotland are 
positive steps.   NICE have announced quality standards to be developed based on these guidelines.  
We hope these form the first steps for continued progress in this potentially common but under-
recognised and often neglected disorder. 
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